244 related articles for article (PubMed ID: 36780950)
1. Androgenetic alopecia incidence in transgender and gender diverse populations: A retrospective comparative cohort study.
Gao JL; Sanz J; Tan N; King DS; Modest AM; Dommasch ED
J Am Acad Dermatol; 2023 Sep; 89(3):504-510. PubMed ID: 36780950
[TBL] [Abstract][Full Text] [Related]
2. Clinicians in the Veterans Health Administration initiate gender-affirming hormone therapy in concordance with clinical guideline recommendations.
Jasuja GK; Wolfe HL; Reisman JI; Vimalananda VG; Rao SR; Blosnich JR; Livingston NA; Shipherd JC
Front Endocrinol (Lausanne); 2024; 15():1086158. PubMed ID: 38800485
[TBL] [Abstract][Full Text] [Related]
3. Effect of gender-affirming hormone therapy on hair growth: a systematic review of the literature.
Tang GT; Zwickl S; Sinclair R; Zajac JD; Cheung AS
Clin Exp Dermatol; 2023 Sep; 48(10):1117-1127. PubMed ID: 37311161
[TBL] [Abstract][Full Text] [Related]
4. Barriers and Facilitators to Gender-affirming Hormone Therapy in the Veterans Health Administration.
Wolfe HL; Boyer TL; Shipherd JC; Kauth MR; Jasuja GK; Blosnich JR
Ann Behav Med; 2023 Nov; 57(12):1014-1023. PubMed ID: 37436725
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of cancer risk factors among transgender and gender diverse individuals: a cross-sectional analysis using UK primary care data.
Brown J; Pfeiffer RM; Shrewsbury D; O'Callaghan S; Berner AM; Gadalla SM; Shiels MS; Jackson SS
Br J Gen Pract; 2023 Jul; 73(732):e486-e492. PubMed ID: 37365010
[TBL] [Abstract][Full Text] [Related]
6. Transgender Patients Report Lower Satisfaction with Care Received than Cisgender Patients Receiving Care in an Academic Medical Care System.
Trinh MH; Quint M; Coon D; Bhasin S; Tocci B; Reisner SL
LGBT Health; 2024 Apr; 11(3):202-209. PubMed ID: 38100315
[No Abstract] [Full Text] [Related]
7. Characteristics of a transgender and gender-diverse patient population in Utah: Use of electronic health records to advance clinical and health equity research.
Ho TF; Zenger B; Mark B; Hiatt L; Sullivan E; Steinberg BA; Lyons A; Spivak AM; Agarwal C; Adelman M; Hotaling J; Kiraly B; Talboys S
PLoS One; 2024; 19(5):e0302895. PubMed ID: 38713697
[TBL] [Abstract][Full Text] [Related]
8. Decreased Anogenital Gonorrhea and Chlamydia in Transgender and Gender Diverse Primary Care Patients Receiving Gender-Affirming Hormone Therapy.
Reisner SL; Deutsch MB; Mayer KH; Pletta DR; Campbell J; Potter J; Keuroghlian AS; Hughto JMW; Asquith A; Pardee DJ; Harris A; Quint M; Grasso C; Gonzalez A; Radix A
J Gen Intern Med; 2024 May; 39(7):1164-1172. PubMed ID: 37989820
[TBL] [Abstract][Full Text] [Related]
9. Gender-affirming pharmacotherapy and additional health considerations: A contemporary review.
Mercer J; Bandy S; Tang H; Wenger B; Ryan L; Lee G; Lipscomb J
J Am Pharm Assoc (2003); 2023; 63(6):1669-1676.e1. PubMed ID: 37619851
[TBL] [Abstract][Full Text] [Related]
10. Association between gender-affirming hormone therapy and measures of glucose metabolism: A longitudinal study.
Anike O; Zhang Q; Bhasin S; Flanders WD; Getahun D; Haw JS; Huybrechts KF; Lash TL; McCracken CE; Roblin D; Silverberg MJ; Suglia SF; Tangpricha V; Vupputuri S; Goodman M
J Clin Endocrinol Metab; 2024 May; ():. PubMed ID: 38815002
[TBL] [Abstract][Full Text] [Related]
11. Adherence to Gender Affirming Hormone Therapy in Transgender Adolescents and Adults: A Retrospective Cohort Study.
Gupta P; Patterson BC; Chu L; Gold S; Amos S; Yeung H; Goodman M; Tangpricha V
J Clin Endocrinol Metab; 2023 Oct; 108(11):e1236-e1244. PubMed ID: 37246711
[TBL] [Abstract][Full Text] [Related]
12. Laboratory Changes During Gender-Affirming Hormone Therapy in Transgender Adolescents.
Millington K; Lee JY; Olson-Kennedy J; Garofalo R; Rosenthal SM; Chan YM
Pediatrics; 2024 May; 153(5):. PubMed ID: 38567424
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer and gender-affirming hormone therapy for transgender and gender-diverse (TGD) individuals.
Cathcart-Rake EJ; Ruddy KJ; Tevaarwerk AJ; Jatoi A
Maturitas; 2024 Mar; 181():107913. PubMed ID: 38262089
[TBL] [Abstract][Full Text] [Related]
14. Estrogen-Based Gender-Affirming Hormone Therapy and Subclinical Cardiovascular Disease in Transgender Women with HIV.
Martinez CA; Rikhi R; Fonseca Nogueira N; Pester MS; Salazar AS; Ashinne B; Aguilar N; Melara A; Porras V; Parker M; Mendez A; Cyrus E; De Santis JP; Jones DL; Brown TT; Hurwitz BE; Alcaide ML
LGBT Health; 2023; 10(8):576-585. PubMed ID: 37459150
[No Abstract] [Full Text] [Related]
15. Cumulative Incidence of All-Cause Knee Injury, Concussion, and Stress Fracture among Transgender Patients on Gender-Affirming Hormone Therapy: An Exploratory Retrospective Cohort Study.
Miro EW; Taylor E; Curtin A; Newman MG; Ose D; Knox J
Int J Environ Res Public Health; 2023 Nov; 20(22):. PubMed ID: 37998291
[TBL] [Abstract][Full Text] [Related]
16. Recruiting Sexual and Gender Minority Veterans for Health Disparities Research: Recruitment Protocol of a Web-Based Prospective Cohort Study.
Fan CA; Upham M; Beaver K; Dashtestani K; Skiby MM; Pentel KZ; Rhew IC; Kauth MR; Shipherd JC; Kaysen D; Simpson T; Lehavot K
JMIR Res Protoc; 2023 Oct; 12():e43824. PubMed ID: 37782536
[TBL] [Abstract][Full Text] [Related]
17. Influence of sex hormone use on sleep architecture in a transgender cohort.
Morssinkhof MWL; van der Werf YD; van den Heuvel OA; van den Ende DA; van der Tuuk K; den Heijer M; Broekman BFP
Sleep; 2023 Nov; 46(11):. PubMed ID: 37715990
[TBL] [Abstract][Full Text] [Related]
18. The association of gender-affirming hormone therapy duration and body mass index on bone mineral density in gender diverse adults.
Iwamoto SJ; Rice JD; Moreau KL; Cornier MA; Wierman ME; Mancuso MP; Gebregzabheir A; Hammond DB; Rothman MS
J Clin Transl Endocrinol; 2024 Jun; 36():100348. PubMed ID: 38756206
[TBL] [Abstract][Full Text] [Related]
19. Addition of progesterone to feminizing gender-affirming hormone therapy in transgender individuals for breast development: a randomized controlled trial.
Dijkman BAM; Helder D; Boogers LS; Gieles NC; van Heesewijk JO; Slaa ST; Liberton NPTJ; Wiepjes CM; de Blok CJM; den Heijer M; Dreijerink KMA
BMC Pharmacol Toxicol; 2023 Dec; 24(1):80. PubMed ID: 38124194
[TBL] [Abstract][Full Text] [Related]
20. Considerations for Gender-Affirming Hormonal and Surgical Care Among Transgender and Gender Diverse Adolescents and Adults With Congenital Heart Disease.
Harrison DJ; Prada F; Nokoff NJ; Iwamoto SJ; Pastor T; Jacobsen RM; Yeung E
J Am Heart Assoc; 2024 Feb; 13(3):e031004. PubMed ID: 38293963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
